REPL vs TFX · $825.7M cap vs P/E 2083, rev $3.05B
Replimune Group Inc (REPL) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
REPL does not have a complete income-statement cache yet.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
REPL currently screens at market cap $825.7M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the REPL and TFX stock pages for the full models.
Not investment advice.